Table 3 Linear Regression Analysis of the Proportion of Patients Willing to Accept LAI Treatment
From: Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
Regression coefficient | Standard Error | p-value | Coefficient | Standard Error | p-value | |
Constant | – | – | – | 23.25 | 11.44 | 0.044 |
Factor 1 “Barriers” | 1.35 | 1.58 | 0.395 | – | – | – |
Factor 2 “Injection-specific barriers” | 3.20 | 1.57 | 0.044 | 2.81 | 1.63 | 0.087 |
Factor 3 “Balancing evidence of benefits” | 1.84 | 1.54 | 0.233 | – | – | – |
Factor 4 “Positive expectations” | 1.02 | 1.55 | 0.511 | – | – | – |
Factor 5 “Influence of colleagues” | 3.59 | 1.53 | 0.020* | 3.67 | 1.51 | 0.016* |
Factor 6 “Needle fear/anxiety” | −0.22 | 1.55 | 0.887 | – | – | – |
Male | 5.42 | 3.44 | 0.117 | – | – | – |
Age (years) | 0.43 | 0.15 | 0.007* | −0.12 | 0.37 | 0.745 |
General adult | −6.38 | 5.77 | 0.271 | – | – | – |
University and other clinic | 2.23 | 3.17 | 0.482 | – | – | – |
Years of experience | 0.43 | 0.16 | 0.011* | 0.55 | 0.39 | 0.165 |
Country | 2.18 | 0.95 | 0.022* | 1.40 | 0.97 | 0.151 |